Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ROS study.

Simple item page
dc.conference.dateJUN 04-08, 2021
dc.conference.titleVirtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
dc.contributor.authorGarcia-Alfonso, Pilar
dc.contributor.authorMunoz Martin, Andres J.
dc.contributor.authorJimenez-Castro, Jeronimo
dc.contributor.authorJimenez-Fonseca, Paula
dc.contributor.authorPericay, Carles
dc.contributor.authorLongo, Federico
dc.contributor.authorReyna, Carmen
dc.contributor.authorArgiles, Guillem
dc.contributor.authorGonzalez Astorga, Beatriz
dc.contributor.authorJose Gomez-Reina, Maria
dc.contributor.authorRuiz Casado, Ana
dc.contributor.authorRodriguez-Salas, Nuria
dc.contributor.authorLopez-Lopez, Rafael
dc.contributor.authorCarmona Bayonas, Alberto
dc.contributor.authorConde-Herrero, Veronica
dc.contributor.authorAranda, Enrique
dc.contributor.authoraffiliationHosp Gen Univ Gregorio Maranon, Madrid, SpainInst Invest Sanitaria Gregorio Maranon, Madrid, SpainHosp Univ Virgen Rocio, Seville, SpainHosp Univ Cent Asturias, Oviedo, SpainHosp Sabadell, Corp Sanitaria Parc Tauli, Sabadell, SpainInst Ramon & Cajal Invest Sanitaria IRICYS, Hosp Univ Ramon & Cajal, CIBERONC, Madrid, SpainHosp Univ Reg & Virgen Victoria, Malaga, SpainVall Hebron Univ Hosp & Inst Oncol VHIO, TTD Grp, CIBERONC, Barcelona, SpainHosp Univ San Cecilio, Granada, SpainHosp Univ Puerta Mar, Cadiz, SpainHosp Univ Puerta Hierro, Dept Med Oncol, Madrid, SpainHosp Univ La Paz, Dept Med Oncol, Madrid, SpainUniv Clin Hosp, Dept Med Oncol, Madrid, SpainUniv Clin Hosp, Translat Med Oncol Grp, Madrid, SpainUniv Clin Hosp, Hlth Res Inst IDIS, Madrid, SpainUniv Santiago Compostela, Sch Med, CIBERONC, Santiago De Compostela, SpainHosp Gen Univ Morales Meseguer, Murcia, SpainHosp Univ Virgen Ias Nieves, Dept Med Oncol, Granada, SpainUniv Cordoba, Reina Sofia Hosp, IMIBIC, Inst Salud Carlos III,CIBERONC, Cordoba, Spain
dc.contributor.funderLaboratorios Servier S. L
dc.date.accessioned2025-01-07T13:08:02Z
dc.date.available2025-01-07T13:08:02Z
dc.date.issued2021-05-20
dc.identifier.doi10.1200/JCO.2021.39.15_suppl.e15556
dc.identifier.essn1527-7755
dc.identifier.issn0732-183X
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc8468101?pdf=render
dc.identifier.urihttps://hdl.handle.net/10668/25274
dc.identifier.wosID708120301221
dc.issue.number15
dc.issue.numberS
dc.journal.titleJournal of clinical oncology
dc.journal.titleabbreviationJ. clin. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Puerta del Mar
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.publisherLippincott williams & wilkins
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleEarly clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ROS study.
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number39
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Puerta del Mar
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario Reina Sofía
SAS - Hospital Universitario San Cecilio
SAS - Hospital Universitario Virgen de la Victoria
Load more

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía